A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach.

Kumar, Shashank; Shuaib, Mohd; Prajapati, Kumari Sunita; Singh, Atul Kumar; Choudhary, Princy; Singh, Sangeeta; Gupta, Sanjay

Kumar, Shashank; Shuaib, Mohd; Prajapati, Kumari Sunita; Singh, Atul Kumar; Choudhary, Princy; Singh, Sangeeta; Gupta, Sanjay.

Afiliación

Kumar S; Molecular Signaling & Drug Discovery Laboratory, Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab 151401 India.
Shuaib M; Molecular Signaling & Drug Discovery Laboratory, Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab 151401 India.
Prajapati KS; Molecular Signaling & Drug Discovery Laboratory, Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab 151401 India.
Singh AK; Molecular Signaling & Drug Discovery Laboratory, Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab 151401 India.
Choudhary P; Applied Science Department, Indian Institute of Information Technology, Allahabad, Uttar Pradesh 211012 India.
Singh S; Applied Science Department, Indian Institute of Information Technology, Allahabad, Uttar Pradesh 211012 India.
Gupta S; Department of Urology, Case Western Reserve University, Cleveland, OH 44106 USA.

3 Biotech ; 12(3): 72, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35223358

Palabras clave

Immune simulation; Molecular docking; Molecular dynamics simulation; Multi-epitope vaccine; Triple-negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: 3 Biotech Año: 2022 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google